Association between delay in diabetes development and mortality in people with obesity: Up to 33 years follow‐up of the prospective Swedish Obese Subjects study
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Lena M S Carlsson und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity, Life Expectancy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health and Medical Care Committee of the Regional Executive Board, Region Västra Götaland, the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement, Vetenskapsrådet.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Life expectancy is reduced in people with obesity and is further reduced in those with concomitant type 2 diabetes. The aim of the study was to assess whether a 2‐year delay in diabetes development influences life expectancy in people with obesity. Materials and Methods Participants from the Swedish Obese Subjects study without diabetes at baseline and known diabetes status at the 2‐year follow‐up were included: bariatric surgery ( n = 1471) and usual obesity care ( n = 1392). Median follow‐up was 26.1 years (interquartile range: 22.7–28.7 years). The Swedish Cause of Death Register, case sheets and autopsy reports were assessed to determine the direct cause of death. Analyses were adjusted for preselected risk factors: inclusion year, sex, baseline age, body mass index (BMI) and smoking.
Results
Across both study arms, 146 participants were newly diagnosed with type 2 diabetes at the 2‐year examination, whereas 2717 remained diabetes‐free. Most participants diagnosed with diabetes ( n = 140) were from the usual care control group. During the follow‐up, there were 18.3 deaths per 1000 person‐years (95% confidence interval [CI]:14.1–23.9) in the group with diagnosed diabetes at the 2‐year follow‐up and 10.9 deaths per 1000 person‐years (95% CI:10.2–11.8) in the group that remained diabetes‐free (adjusted hazard ratio [HRadj] 1.60, 95% CI: 1.19–2.15, p = 0.002). The adjusted median life expectancy in the diabetes group was 3.7 years (95% CI: 1.4–6.0, p = 0.002) shorter than in the diabetes‐free group. Specifically, cardiovascular mortality was higher in the group with diabetes (adj sub‐hazard ratio [sub‐HR] 1.74 [95% CI: 1.09–2.77], p = 0.021).
Conclusions
A 2‐year delay in diabetes development may be linked to increased life expectancy, possibly due to a reduction in cardiovascular mortality. Future studies should confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), and Late-Stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
- Department of Oncology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Region Västra Götaland, NU Hospital Group, Department of Clinical Physiology, Trollhättan, Sweden.
- Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
- Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
ORCID-Profile: Lena M S Carlsson, Peter Jacobson, Johanna C Andersson-Assarsson, Sofie Ahlin, Ingmar Näslund, Per-Arne Svensson, Magdalena Taube, Markku Peltonen, Kajsa Sjöholm
Förderung
- Health and Medical Care Committee of the Regional Executive Board, Region Västra Götaland
- the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement
- Vetenskapsrådet
- Adlerbertska Research Foundation
- Diabetesfonden
- Hjärt-Lungfonden
- Svenska Diabetesförbundet
- Diabetesförbundet
Zitieren
APA
Carlsson, L. M. S., Carlsson, B., Jacobson, P., Andersson-Assarsson, J. C., Karlsson, C., Kristensson, F. M., Ahlin, S., Näslund, I., Karason, K., Svensson, P. A., Taube, M., Peltonen, M., & Sjöholm, K. (2025). Association between delay in diabetes development and mortality in people with obesity: Up to 33 years follow‐up of the prospective Swedish Obese Subjects study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16010
Vancouver
Carlsson LMS, Carlsson B, Jacobson P, Andersson-Assarsson JC, Karlsson C, Kristensson FM, et al. Association between delay in diabetes development and mortality in people with obesity: Up to 33 years follow‐up of the prospective Swedish Obese Subjects study. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16010
BibTeX
@article{Carlsson2025,
author = {Carlsson, Lena M S and Carlsson, Björn and Jacobson, Peter and Andersson-Assarsson, Johanna C and Karlsson, Cecilia and Kristensson, Felipe M and Ahlin, Sofie and Näslund, Ingmar and Karason, Kristjan and Svensson, Per-Arne and Taube, Magdalena and Peltonen, Markku and Sjöholm, Kajsa},
title = {Association between delay in diabetes development and mortality in people with obesity: Up to 33 years follow‐up of the prospective Swedish Obese Subjects study},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16010}
}
EUVIMED